Since then, additional mutations in the mtDNA have been associated with elevated fasting insulin (4), increased fasting plasma glucose (5), increased Homeostatic Model Assessment of Insulin Resistance (HOMA-IR) values (6), as well as type 2 diabetes (7, 8) and metabolic syndrome (6). This evidence concerns the gene INS and Insulin resistance.